Retatrutide 40mg

Description

Retatrutide 40 mg is the highest-concentration format we offer of the triple-agonist peptide Retatrutide. Intended for laboratory research requiring extended working stock from a single vial.

Research Profile

• Triple-agonist activity across GIP, GLP-1, and glucagon receptors
• Studied in metabolic, energy-expenditure, and glucose-handling research
• Maximum-concentration format for long-term studies
• QC verified by HPLC and mass spectrometry

Specifications

• Compound: Retatrutide (LY3437943)
• Dosage: 40 mg per vial
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.